Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Cv Sciences Inc
(OP:
CVSI
)
0.0240
+0.0006 (+2.56%)
Streaming Delayed Price
Updated: 1:11 PM EDT, Aug 12, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Cv Sciences Inc
< Previous
1
2
3
4
5
6
7
8
9
10
Next >
Marijuana Stock Movers For August 15, 2023
↗
August 15, 2023
Via
Benzinga
Topics
Cannabis
Publicly Traded Hemp-Focused Wellness Company Reports Q2 Results, Here Is What You Need To Know
↗
August 14, 2023
CV Sciences, Inc. (OTCQB: CVSI) reported Monday its financial results for the quarter ended June 30, 2023, disclosing revenue of $4.0 million, compared to $4.1 million for the same period of 2022.
Via
Benzinga
CV Sciences FY22 Revenue Declines 19% To $16.2M
↗
March 29, 2023
CV Sciences, Inc. (OTCQB: CVSI) FY 2022 revenue was $16.2 million, a 19% decrease compared to $20.0 million for 2021. Q4 2022 Financial Highlights
Via
Benzinga
Why Is CV Sciences Stock Up Today?
↗
November 14, 2022
CV Sciences (OTCQB: CVSI) shares were trading 10.69% higher at $0.044 per share at the time of writing Monday morning on company's third-quarter financial results.
Via
Benzinga
CV Sciences Adds +PlusCBD Relief Softgels To Wellness Line Of CBD Products
↗
March 08, 2022
CV Sciences, Inc. (OTCQB:CVSI) added +PlusCBD ...
Via
Benzinga
Cannabis Stock Gainers And Losers From August 14, 2023
↗
August 14, 2023
Via
Benzinga
Topics
Cannabis
Bearish Monday For Marijuana Stocks - EVIO, Item 9 Labs Among Top Gainers
↗
August 07, 2023
Via
Benzinga
Cannabis Stock Gainers And Losers From August 11, 2023
↗
August 11, 2023
Via
Benzinga
Topics
Cannabis
Marijuana Stock Movers For July 17, 2023
↗
July 17, 2023
Via
Benzinga
Marijuana Stock Movers For August 8, 2023
↗
August 08, 2023
Via
Benzinga
Bullish Thursday For Marijuana Stocks - Choom Holdings, EVIO Among Top Gainers
↗
July 13, 2023
Via
Benzinga
Cannabis Stock Gainers And Losers From August 4, 2023
↗
August 04, 2023
Via
Benzinga
Marijuana Stock Movers For July 12, 2023
↗
July 12, 2023
Via
Benzinga
Marijuana Stock Movers For August 2, 2023
↗
August 02, 2023
Via
Benzinga
Cannabis Stock Gainers And Losers From July 11, 2023
↗
July 11, 2023
Via
Benzinga
Marijuana Stock Movers For July 31, 2023
↗
July 31, 2023
Via
Benzinga
Cannabis Stock Movers For July 10, 2023
↗
July 10, 2023
Via
Benzinga
Cannabis Stock Gainers And Losers From July 28, 2023
↗
July 28, 2023
Via
Benzinga
CV Sciences Inc Q1 Revenue Stagnates YoY, Here Is What You Need To Know
↗
May 15, 2023
CV Sciences, Inc. (OTCQB: CVSI) released its financial results today for the first quarter ended March 31, 2023, revealing revenues of $4.1 million for the first quarter of 2023 compared to $4.4...
Via
Benzinga
Cannabis Stock Gainers And Losers From July 26, 2023
↗
July 26, 2023
Via
Benzinga
Popular CBD Brand Questions Study: 'Misleading To Consumers And Damaging To The Industry'
↗
April 10, 2023
NextEvo Naturals recently released results from a third-party study on 16 CBD products that were allegedly randomly selected for the research. The brand commissioned Coral Reef Labs to conduct this...
Via
Benzinga
CBD And Nicotine Formula To Treat Smokeless Tobacco Addiction Receives Patent From Japan, FDA Approval Next
↗
March 23, 2023
CV Sciences, Inc. (OTCQB: CVSI) received a formal certificate of grant from the Japan Patent Office for its patent application 7216697.
Via
Benzinga
Cannabis Stock Movers For July 24, 2023
↗
July 24, 2023
Via
Benzinga
Biden's Pardon For Cannabis Offenders: 27 Reactions From Politicians, Industry Executives And Advocacy Orgs
↗
October 07, 2022
President Joe Biden announced on Thursday that he will pardon all prior federal offenses for simple marijuana possession, sending
Via
Benzinga
Cannabis Stock Movers For July 19, 2023
↗
July 19, 2023
Via
Benzinga
The CBD Gold Rush Is Over (And That's A Great Thing For Consumers)
↗
August 24, 2022
By Bharat Ayyar Disclaimer: I am not a financial advisor. Nothing contained in this post should be construed as investment advice. CV Sciences (OTC: CVSI), the company behind +PlusCBD, had a meteoric...
Via
Benzinga
Marijuana As An Appetite Suppressant? It's A Possibility
↗
June 30, 2022
Using cannabis as an appetite suppressant for weight management may seem counterintuitive, but one rare cannabinoid may have just that effect. Delta-9 (d-9)-dominant tetrahydrocannabivarin (THCV) has...
Via
Benzinga
CV Sciences Q1 Revenue Down 8.33%, CEO Encouraged As PlusCBD Brand Gains Market Share
↗
May 16, 2022
CV Sciences, Inc. (OTCQB: CVSI) released its financial results for the quarter ended March 31, 2022, revealing a revenue drop of 8.33% to $4.4 million YoY. First Quarter 2022 and Recent Financial and...
Via
Benzinga
A Preview Of CV Sciences's Earnings
↗
March 30, 2022
CV Sciences (OTC:CVSI) is set to give its latest quarterly earnings report on Thursday, 2022-03-31. Here's what investors need to know before the announcement. Analysts estimate that CV Sciences will...
Via
Benzinga
Dry January Got You Down? Cannabis To The Rescue With Tokes, Yummy Gummies And More
↗
January 11, 2022
After the hustle and bustle of the holidays, many people are looking to curtail their consumption of alcohol and are therefore partaking in
Via
Benzinga
< Previous
1
2
3
4
5
6
7
8
9
10
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
